Initial studies characterized CYLD as a key regulator of the NFκB pathway and because of the well-known role of NFκB in inducing prosurvival genes, its tumor suppressor function was largely thought to be via suppression of NFκB44. The gene discussed is CYLD; the disease is neoplasm.